Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Digestion
|
January 1, 1980
HBeAg/anti-HBe system and cell-mediated immunity in patients with HBsAg-positive chronic active hepatitis
G Pastore, A Tursi, M P Loria, et al.
Infection
|
January 1, 1979
Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity
G Pastore, A R Zanetti, P Ferroni, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
December 1, 1981
[Sensitivity and specificity of 2 methods of determining surface antigen (HBsAg) in various forms of hepatitis B pathology]
P Dentico, L Baldi, F Trotta, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
September 1, 1982
[Comparative evaluation of 5 third-generation methods for the detection of HBsAg]
P Dentico, L Baldi, F Trotta, et al.
Infection
|
September 1, 1992
Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients
P Dentico, R Buongiorno, A Volpe, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia
|
May 1, 1975
[Studies on the physiopathology of cholera in Bari]
O Schiraldi, F Lonero, S Marotti, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
March 1, 1979
[Prognostic value of alpha-foetoprotein in fulminant hepatitis (author's transl)]
G Pastore, E Lapedota, P Dentico, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
October 30, 1980
[Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)]
R Buongiorno, P Dentico, T Santantonio, et al.
Microbios
|
January 7, 2000
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients
P Dentico, R Sacco, R Buongiorno, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone
P Bernardeschi, P Dentico, S Rossi, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Digestion
|
January 1, 1980
HBeAg/anti-HBe system and cell-mediated immunity in patients with HBsAg-positive chronic active hepatitis
G Pastore, A Tursi, M P Loria, et al.
Infection
|
January 1, 1979
Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity
G Pastore, A R Zanetti, P Ferroni, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
December 1, 1981
[Sensitivity and specificity of 2 methods of determining surface antigen (HBsAg) in various forms of hepatitis B pathology]
P Dentico, L Baldi, F Trotta, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
September 1, 1982
[Comparative evaluation of 5 third-generation methods for the detection of HBsAg]
P Dentico, L Baldi, F Trotta, et al.
Infection
|
September 1, 1992
Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients
P Dentico, R Buongiorno, A Volpe, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia
|
May 1, 1975
[Studies on the physiopathology of cholera in Bari]
O Schiraldi, F Lonero, S Marotti, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|
March 1, 1979
[Prognostic value of alpha-foetoprotein in fulminant hepatitis (author's transl)]
G Pastore, E Lapedota, P Dentico, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
October 30, 1980
[Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)]
R Buongiorno, P Dentico, T Santantonio, et al.
Microbios
|
January 7, 2000
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients
P Dentico, R Sacco, R Buongiorno, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone
P Bernardeschi, P Dentico, S Rossi, et al.
Page
of 7